Furthermore, the examination of the association between RIT1 mRNA expression levels as well as clinicopathological features in a cohort of 98 patients with glioma (Table S1) revealed a significant interplay with tumour size (p < 0.001), Karnofsky Performance Status (KPS) (p = 0.012), WHO tumour stage (p < 0.001), and tumour recurrence (p = 0.025). Here, RIT1 is linked to central nervous system cancer.